Abstract 2211: Enhancedin vitroandin vivotargeting of rituximab-sensitive and -resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR)-modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin

2016 ◽  
Author(s):  
Yaya Chu ◽  
Ashlin Yahr ◽  
Bokun Cheng ◽  
Bian Hang ◽  
Janet Ayello ◽  
...  
Keyword(s):  
Natural Killer Cells ◽  
Natural Killer ◽  
Histone Deacetylase ◽  
Chimeric Antigen Receptor ◽  
Burkitt Lymphoma ◽  
Histone Deacetylase Inhibitor ◽  
Antigen Receptor ◽  
Killer Cells ◽  
Deacetylase Inhibitor ◽  
Anti Cd20

scholarly journals Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers

2017 ◽  
Vol 25 (12) ◽  
pp. 2607-2619 ◽  
Author(s):  
Elizabeth L. Siegler ◽  
Yu Jeong Kim ◽  
Xianhui Chen ◽  
Natnaree Siriwon ◽  
John Mac ◽  
...  
Keyword(s):  
Natural Killer Cells ◽  
Cancer Therapy ◽  
Natural Killer ◽  
Chimeric Antigen Receptor ◽  
Antigen Receptor ◽  
Drug Carriers ◽  
Killer Cells ◽  
Combination Cancer Therapy
Sign in / Sign up

Export Citation Format

Share Document